Literature DB >> 20427530

Role for complement in the development of seizures following acute viral infection.

Jane E Libbey1, Nikki J Kirkman, Karen S Wilcox, H Steve White, Robert S Fujinami.   

Abstract

Complement, part of the innate immune system, acts to remove pathogens and unwanted host material. Complement is known to function in all tissues, including the central nervous system (CNS). In this study, we demonstrated the importance of the complement system within the CNS in the development of behavioral seizures following Theiler's murine encephalomyelitis virus (TMEV) infection. C57BL/6 mice, deficient in complement component C3, developed significantly fewer behavioral seizures following TMEV infection, whereas mice depleted of complement component C3 in the periphery through treatment with cobra venom factor had a seizure rate comparable to that of control mice. These studies indicate that C3 participates in the induction of acute seizures during viral encephalitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427530      PMCID: PMC2903264          DOI: 10.1128/JVI.00422-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules.

Authors:  R C Armstrong; L Harvath; M E Dubois-Dalcq
Journal:  J Neurosci Res       Date:  1990-11       Impact factor: 4.164

2.  A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus.

Authors:  I Tsunoda; Y Iwasaki; H Terunuma; K Sako; Y Ohara
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

3.  Immunoglobulins and complement in demyelination induced in mice by Theiler's virus.

Authors:  M Rodriguez; C F Lucchinetti; R J Clark; T L Yakash; H Markowitz; V A Lennon
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

4.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

5.  Chemotaxis by a CNS macrophage, the microglia.

Authors:  J Yao; L Harvath; D L Gilbert; C A Colton
Journal:  J Neurosci Res       Date:  1990-09       Impact factor: 4.164

6.  A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.

Authors:  A Zurbriggen; R S Fujinami
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 7.  Complement C3 deficiency: human, animal, and experimental models.

Authors:  L Singer; H R Colten; R A Wetsel
Journal:  Pathobiology       Date:  1994       Impact factor: 4.342

Review 8.  Complement biosynthesis in the central nervous system.

Authors:  S R Barnum
Journal:  Crit Rev Oral Biol Med       Date:  1995

9.  Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis.

Authors:  B Dietzschold; W Schwaeble; M K Schäfer; D C Hooper; Y M Zehng; F Petry; H Sheng; T Fink; M Loos; H Koprowski; E Weihe
Journal:  J Neurol Sci       Date:  1995-05       Impact factor: 3.181

10.  Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines.

Authors:  P Gasque; M Fontaine; B P Morgan
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

View more
  21 in total

1.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

2.  Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Neurovirol       Date:  2011-08-11       Impact factor: 2.643

Review 3.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

4.  Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection.

Authors:  Jane E Libbey; Matthew F Cusick; Daniel J Doty; Robert S Fujinami
Journal:  Viral Immunol       Date:  2017-04-12       Impact factor: 2.257

5.  Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

6.  Indoleamine 2,3-dioxygenase 1 deletion promotes Theiler's virus-induced seizures in C57BL/6J mice.

Authors:  Michal B Juda; Alexandra K Brooks; Albert E Towers; Gregory G Freund; Robert H McCusker; Andrew J Steelman
Journal:  Epilepsia       Date:  2019-02-15       Impact factor: 5.864

7.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

8.  Infiltrating macrophages are key to the development of seizures following virus infection.

Authors:  Matthew F Cusick; Jane E Libbey; Dipan C Patel; Daniel J Doty; Robert S Fujinami
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

9.  The immune response to picornavirus infection and the effect of immune manipulation on acute seizures.

Authors:  Ana Beatriz DePaula-Silva; F Lynn Sonderegger; Jane E Libbey; Daniel J Doty; Robert S Fujinami
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

Review 10.  Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

Authors:  Ana Beatriz DePaula-Silva; Tyler J Hanak; Jane E Libbey; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2017-02-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.